RATIONALE: Exposure to particulates from burning biomass is an increasing global health issue. Burning biomass, including wood smoke, is associated with increased lower respiratory infections. OBJECTIVES: To determine whether acute exposure to wood smoke modifies nasal inflammatory responses to influenza. METHODS:Healthy young adults (n = 39) were randomized to a 2-hour controlled chamber exposure to wood smoke, where exposure levels were controlled to particulate number (wood smoke particles [WSP]; 500 μg/cm3) or filtered air, followed by nasal inoculation with a vaccine dose of live attenuated influenza virus (LAIV). Nasal lavage was performed before exposure (Day 0) and on Days 1 and 2 after exposure. Nasal lavage fluid cells were analyzed for inflammatory gene expression profiles, and cell-free fluid was assayed for cytokines. MEASUREMENTS AND MAIN RESULTS:Only IP-10 protein levels were affected, suppressed, by WSP exposure in aggregate analysis. Subsequent analysis indicated an exposure × sex interaction, prompting additional analyses of WSP- and LAIV-induced changes in males and females. Inflammation-related gene expression profiles differed between the sexes, at baseline (males greater than females), after LAIV inoculation (females greater than males), and after WSP exposure (increase in males and decrease in females), demonstrating that WSP- and LAIV-induced changes in antiviral defense responses in the nasal mucosa occur in a sex-specific manner. CONCLUSIONS: WSP exposure resulted in minimal modification of LAIV-induced responses in aggregate analysis. In contrast, analyzing WSP-induced modification of LAIV responses in the sexes separately unmasked sex-specific differences in response to exposure. These data highlight the need for additional studies to understand sex-specific pollutant-induced effects. Clinical trial registered with www.clinicaltrials.gov (NCT02183753).
RCT Entities:
RATIONALE: Exposure to particulates from burning biomass is an increasing global health issue. Burning biomass, including wood smoke, is associated with increased lower respiratory infections. OBJECTIVES: To determine whether acute exposure to wood smoke modifies nasal inflammatory responses to influenza. METHODS: Healthy young adults (n = 39) were randomized to a 2-hour controlled chamber exposure to wood smoke, where exposure levels were controlled to particulate number (wood smoke particles [WSP]; 500 μg/cm3) or filtered air, followed by nasal inoculation with a vaccine dose of live attenuated influenza virus (LAIV). Nasal lavage was performed before exposure (Day 0) and on Days 1 and 2 after exposure. Nasal lavage fluid cells were analyzed for inflammatory gene expression profiles, and cell-free fluid was assayed for cytokines. MEASUREMENTS AND MAIN RESULTS: Only IP-10 protein levels were affected, suppressed, by WSP exposure in aggregate analysis. Subsequent analysis indicated an exposure × sex interaction, prompting additional analyses of WSP- and LAIV-induced changes in males and females. Inflammation-related gene expression profiles differed between the sexes, at baseline (males greater than females), after LAIV inoculation (females greater than males), and after WSP exposure (increase in males and decrease in females), demonstrating that WSP- and LAIV-induced changes in antiviral defense responses in the nasal mucosa occur in a sex-specific manner. CONCLUSIONS: WSP exposure resulted in minimal modification of LAIV-induced responses in aggregate analysis. In contrast, analyzing WSP-induced modification of LAIV responses in the sexes separately unmasked sex-specific differences in response to exposure. These data highlight the need for additional studies to understand sex-specific pollutant-induced effects. Clinical trial registered with www.clinicaltrials.gov (NCT02183753).
Entities:
Keywords:
air pollution; nasal mucosa; sex difference; viral infection
Authors: Christopher T Migliaccio; Emily Kobos; Quinton O King; Virginia Porter; Forrest Jessop; Tony Ward Journal: Inhal Toxicol Date: 2013-02 Impact factor: 2.724
Authors: Adriana Forero; Katherine Fenstermacher; Nicholas Wohlgemuth; Andrew Nishida; Victoria Carter; Elise A Smith; Xinxia Peng; Melissa Hayes; Doreen Francis; John Treanor; Juliet Morrison; Sabra L Klein; Andrew Lane; Michael G Katze; Andrew Pekosz Journal: Vaccine Date: 2017-09-28 Impact factor: 3.641
Authors: Alexis D Payton; Alexia N Perryman; Jessica R Hoffman; Vennela Avula; Heather Wells; Carole Robinette; Neil E Alexis; Ilona Jaspers; Julia E Rager; Meghan E Rebuli Journal: Am J Physiol Lung Cell Mol Physiol Date: 2022-03-23 Impact factor: 5.464
Authors: Adam M Speen; Jessica R Hoffman; Hye-Young H Kim; Yael N Escobar; Grace E Nipp; Meghan E Rebuli; Ned A Porter; Ilona Jaspers Journal: Chem Res Toxicol Date: 2019-09-11 Impact factor: 3.739
Authors: Crystal M North; Piers MacNaughton; Peggy S Lai; Jose Vallarino; Samson Okello; Bernard Kakuhikire; Alexander C Tsai; Marcia C Castro; Mark J Siedner; Joseph G Allen; David C Christiani Journal: Environ Health Date: 2019-08-20 Impact factor: 7.123
Authors: Julia E Rager; Jeliyah Clark; Lauren A Eaves; Vennela Avula; Nicole M Niehoff; Yong Ho Kim; Ilona Jaspers; M Ian Gilmour Journal: Sci Total Environ Date: 2021-02-10 Impact factor: 7.963
Authors: Aaron Vose; Matthew McCravy; Anastasiya Birukova; Zhonghui Yang; John W Hollingsworth; Loretta G Que; Robert M Tighe Journal: Toxicol Appl Pharmacol Date: 2021-07-13 Impact factor: 4.460
Authors: Qixin Wang; Naushad Ahmad Khan; Thivanka Muthumalage; Gina R Lawyer; Samantha R McDonough; Tsai-Der Chuang; Ming Gong; Isaac K Sundar; Virender K Rehan; Irfan Rahman Journal: FASEB Bioadv Date: 2019-08-23